This special report aims to inform the medical community about the many challenges
involved in managing radiation exposure in a way that maximizes the benefit-risk ratio. The …

The potential of α-particle emitters to treat cancer has been recognized since the early
1900s. Advances in the targeted delivery of radionuclides and radionuclide conjugation …

As a treatment modality that is fundamentally different from other therapies against cancer,
radiopharmaceutical therapy with alpha-particle emitters has drawn the attention of the …

Effective dose was introduced by the ICRP for the single, over-arching purpose of setting
limits for radiation protection. Effective dose is a derived quantity or mathematical construct …

The International Commission on Radiation Units and Measurements (ICRU) Report
Committee on “Bioeffect Modeling and Biologically Equivalent Dose Concepts in Radiation …

Synovial sarcomas are rare tumors arising in adolescents and young adults. The prognosis
for advanced disease is poor, with an overall survival of 12‐18 months. Frizzled homolog 10 …

In molecular radiotherapy a radionuclide or a radioactively labelled pharmaceutical is
administered to the patient. Treatment planning therefore comprises the determination of …

The enzymatic hydrolysis yield of rice bran fiber (RBF) was enhanced by the electron beam
irradiation (EBI) pretreatment. Furthermore, the compositional analysis, structural changes …

Radioligand therapy is a type of internal radiotherapy combining a short-range radioisotope
labeled to a carrier with a high affinity for a specific receptor expressed on tumor cells …

As a consequence of the high potency and short range of alpha-particles,
radiopharmaceutical therapy with alpha-particle emitting radionuclides is a promising …